CHAI&ampamp生殖健康供应联盟：2018年全球计生用品市场报告（英文版）（48页）.pdf

1、Please noteIn 2019,updates to historical datasets were made upon consultation with relevant current suppliers,including the addition of a new suppliers data.As a result,the 2015,2016,2017,and 2018 reports do not reflect the most comprehensive,up-to-date information.Please find the most recent report

2、 here.D E C E M B E R 201 8AC K N OW L E D G E M E N TS:This report was produced as part of the landmark FP2020 Global Markets Visibility Project that the Clinton Health Access Initiative,Inc.(CHAI)launched in early 2014 in conjunction with the Reproductive Health Supplies Coalition(RHSC).The shipme

3、nt data provided by suppliers is the foundation of the reports analyses,and allows CHAI to address information gaps and construct a more comprehensive view of the reproductive health commodities market.We would like to thank current participating suppliers(Bayer,CR Zizhu,Cipla,Cupid,Female Health Co

4、mpany,Helm AG*,Merck(MSD),Mylan,Pfizer,Pregna,PT Tunggal,Shanghai Dahua,SMB,and Techno Drugs),as well as our partner,the Concept Foundation,for their support in collecting and aggregating data from the Generic Manufacturers for Reproductive Health(the GEMS Caucus).We are also grateful to our colleag

5、ues from the Coordinated Supply Planning Group(CSP),John Snow Inc.(JSI),United Nations Population Fund(UNFPA),the United States Agency for International Development(USAID),the Global Health Supply-Chain Procurement and Supply-Management(GHSC-PSM),and FP2020,for their invaluable feed-back during the

6、development and refinement of various market analyses.*HELM AG was a participating supplier in the FP2020 Global Markets Visibility Project for the FP 2015,2016 and 2017 Market Reports.In September 2017,HELM AG sold its wholly-owned subsidiary company,HELM Medical GmbH,to Sanavita Pharmaceuticals Gm